autism, the rates of AS were consistently lower by a factor of about 4.
2 Therefore, the prevalence of all PDDs can therefore be conservatively estimated at 27.5/10 000 combining the estimates for autistic disorder, AS and PDD-NOS.
However, in new epidemiological surveys, [3] [4] [5] prevalence estimates were twice as high, at around the 60/10 000 figure for the combined rate of PDDS (Table 1 ). Methodological features shared by these surveys were the active ascertainment techniques to identify cases in the community, reliance on standardised diagnostic measures of known reliability and validity, and a focus on young age groups and on the whole spectrum of autism disorders. If such findings are replicated, a better estimate for the rate of PDDs might well be in the 60-70/10 000 range.
A consistent preponderance of males has been reported with, on average, a male : female ratio of 4.2:1 across surveys. This male : female ratio is higher in those subjects with mild or no mental retardation and lower (around 2 : 1) in more severely retarded samples. On average, the rate of mental retardation is around 70% with 30% of subjects scoring in the normal range of intellectual functioning, 30% in the mild to moderate range of mental retardation, and 40% in the severe to profound range of mental retardation. Some medical disorders which might be causally related to autism have been reported in surveys. Tuberous sclerosis has an average rate of 1.2% in samples of autistic children. Fragile X is also raised in autism. Other rare medical conditions such as congenital rubella, phenylketonuria or neurofibromatosis, are only very occasionally reported. On the whole, in epidemiological surveys, 6.4% of subjects had an associated medical disorder of potential etiological significance. Epilepsy, which mostly develops after autism is already present, was found in about 17% of autistic children, although this might represent an underestimate as epilepsy in autism often develops in adolescence and samples included in surveys have seldom passed entirely through the risk period for epilepsy. There is no association with social class in surveys conducted since 1980. Reports of an increased prevalence of autism in immigrants or in particular ethnic groups are anecdotal and not supported in large investigations. It is difficult to detect geographical differences in prevalence rates since methodological variation between studies confounds cross-country comparisons. Few time and space clustering reports of cases of autism are available but none of these reports have been investigated using adequate epidemiological methods.
The issue of secular changes in rates of autism has been debated recently. To assess time trends in autism, incidence (rather than prevalence) rates, which are more adequate measures of disease occurrence to monitor trends, are not available. Secondly, a strong trend in all countries towards earlier identification and diagnosis of children with PDDs needs to be taken into account to interpret the observed increase. Thirdly, most studies lack statistical power to test for time trends. Fourthly, significant changes in the concepts of autism, its operational definition in diagnostic assessments, and in the efficiency of case-finding methods must be taken into consideration. Unless a strict control of these methodological issues is achieved, variations in rates remain uninterpretable.
There have been five approaches to assess time trends in autism. The first approach has been to compare prevalence rates in studies conducted at several points in time. This approach fails to control for all the methodological sources of artefacts outlined above. To illustrate this, Table 2 summarises the findings of eight recent surveys conducted in the UK 3-7 and the USA.
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These investigations were conducted in the same two countries, at the same time, in similar age groups, and therefore prevalence estimates should be comparable. Nevertheless, there is a 6-fold variation within UK rates and a 14-fold variation within USA rates, which clearly illustrate the impact of method factors on estimates. In both sets of studies, low rates are associated with casefinding techniques relying upon educational service providers, whereas studies based on proactive ascertainment techniques yielded much higher rates. The second approach has used referral statistics reported by providers of educational services, but such studies fail to control for methodological confounding factors. 11 The same applies to the third approach, which compared rates estimated in repeat surveys in the same geographical area. 12 A fourth approach tested the hypothesis of a secular increase in comparing rates in successive birth cohorts surveyed with rigorously comparable methods, but no statistical difference in rates was found. 13 Finally, the fifth approach is represented by two recent incidence studies 14, 15 which both showed increased incidence rates in the early 1990s. However, validation of the diagnosis was poor in one study and non-existent in the other, and no adjustment for changes over time in diagnostic concepts and sensitivity of case finding in both studies was made.
Most epidemiological surveys of autism and PDDs have thus far not been informative to address the hypothesis of an underlying secular increase in the incidence of these disorders. Those studies which have provided indirect tests of this hypothesis have generally failed to control for changes in case-definition and case-finding methods and differences found in rates at different points in time are, therefore, impossible to interpret. Prevalence estimates of autism and PDDs have gone up during the last 20 years but this trend cannot simply be interpreted as evidence of a secular increase in the incidence of the disorder. Prospective surveillance data are required to test adequately this hypothesis.
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